Picture of Imugene logo

IMU Imugene Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Imugene, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital4.826.5412.6013.9
Other Operating Cash Flow
Cash from Operating Activities-13.3-30.8-31.5-102-75.6
Capital Expenditures-5.45-0.258-9.46-7.55
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.1210.0371.72.2-5.15
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-5.33-0.2211.7-7.25-12.7
Financing Cash Flow Items-0.131-7.53-5.04-2.74-1.48
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities181018349.417.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.6270.453.3-60-71.2